Recent Developments at Computer Software Companies: Special Research on Marketo, Materialise, MedAssets, Medical Transcription Billing, and Medidata
NEW YORK, March 18, 2015 /PRNewswire/ --
Editor Note: For more information about this release, please scroll to bottom.
Moments ago, Analysts Review released new research updates concerning several important developing situations including Marketo (NASDAQ: MKTO), Materialise (NASDAQ: MTLS), MedAssets (NASDAQ: MDAS), Medical Transcription Billing (NASDAQ: MTBC), and Medidata (NASDAQ: MDSO). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
To access our full PDF reports on a complementary basis, please visit the links below.
--
Today's update concerns the following companies:
============
Full PDF Download Links (you may have to copy and paste the following links into your browser):
MKTO Research Report: ( http://get.analystsreview.com/pdf/?c=Marketo&d=18-Mar-2015&s=MKTO ),
MTLS Research Report: ( http://get.analystsreview.com/pdf/?c=Materialise&d=18-Mar-2015&s=MTLS ),
MDAS Research Report: ( http://get.analystsreview.com/pdf/?c=MedAssets&d=18-Mar-2015&s=MDAS ),
MTBC Research Report: ( http://get.analystsreview.com/pdf/?c=Medical%20Transcription%20Billing&d=18-Mar-2015&s=MTBC),
MDSO Research Report: ( http://get.analystsreview.com/pdf/?c=Medidata&d=18-Mar-2015&s=MDSO ).
============
--
Analyst Update: New Customers, Quarterly Results, and Products Launch
Reviewed by: Rohit Tuli, CFA®
US stocks closed lower on Tuesday as investors await the end of a two-day Federal Reserve meeting and many are speculating the central bank to pave the way to an interest-rate hike as early as this summer. The S&P 500 declined 6.91 points, or 0.33%, to end at 2074.28, and the Dow Jones Industrial Average fell 128.34 points or 0.71% to 17849.08. Meanwhile, the tech-heavy NASDAQ edged up 7.92 points or 0.16% to close at 4937.43. On economic front, new U.S. homes construction plummeted by 17% to an annual rate of 897,000 in February, while Economists had been expecting housing starts to dip to 1.048 million. European benchmark indices mostly ended lower on Tuesday, partly due to profit taking, and reports of sluggish Eurozone employment growth in the fourth quarter. Germany's DAX 30 fell 186.87 points or 1.54% to 11,980.85, and Eurostoxx 50 was lower 34.59 points or 0.93% to 3,672.16. France's CAC 40 declined 32.23 points or 0.64% to 5,028.93.
Marketo, Inc. (Marketo) announced that Redstone Federal Credit Union (Redstone), the largest credit union in Alabama and one of the 25 largest federal credit unions in the nation, has selected Marketo's engagement marketing platform.
Materialise NV's (Materialise) revenue for Q4 2014 increased 20.9% YoY to EUR 23.6 million led by a strong gain in the software segment revenues and solid double-digit growth in the medical and industrial production segments revenues. However, adjusted EBITDA stood at EUR 0.9 million versus EUR 2.3 million in Q4 2013.
MedAssets, Inc.'s (MedAssets) National Collaborative Program, a sourcing program designed to generate cost reductions for products and services through pre-committed purchasing volume, is expected to generate an estimated $2 million in savings annually in the linen and apparel category.
Medical Transcription Billing, Corp. (MTBC) has launched MTBC Site Builder™, a web-based tool that allows medical practices to design, optimize and promote their own websites.
Medidata Solutions, Inc. (Medidata) was selected to support the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry, a 10-year project to collect comprehensive data on pediatric rheumatic diseases and their treatments. To support its long-term research efforts, the registry is leveraging Medidata's cloud-based technology for electronic data capture and management (Medidata Rave®) and mobile solution for patient-direct data capture (Medidata Patient Cloud®).
--
About Analysts Review
At Analysts Review, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.
Analysts Review was designed for investors. By providing the best information available, we have set ourselves apart as one of the premier online investor communities.
--
Editor Note: This is not company news. We are an independent source and our views do not reflect the companies mentioned.
Compliance Procedure: Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA®. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
Further Resources: For more information about this release including editorial notes, compliance procedures and legal disclosures, please visit: http://www.analystsreview.com/editors
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts Review
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article